Perceptive Advisors »

Grail shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Grail (GRAL) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Grail

Tip: Access up to 7 years of quarterly data

All positions including Grail held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Grail by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $20M 237k 85.59

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Celcuity (CELC)
Rhythm Pharmaceuticals (RYTM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apogee Therapeutics (APGE)
Roivant Sciences SHS (ROIV)
Nuvalent Inc-a (NUVL)
Travere Therapeutics (TVTX)
Spdr Series Trust State Street Spd Put Option (XBI)
EXACT Sciences Corporation (EXAS)
Protagonist Therapeutics (PTGX)
Inhibrx Biosciences (INBX)
Edgewise Therapeutics (EWTX)
Immatics SHS (IMTX)
Spyre Therapeutics Com New (SYRE)

View all positions for Perceptive Advisors

Top funds holding Grail

BlackRock
Farallon Capital Management
Baker Bros. Advisors
Vanguard Group
PRIMECAP Management Company
State Street Corporation
Susquehanna International
CRCM
Fort Hoosac Management
Deep Track Capital
Geode Capital Management
Goldman Sachs Group
Alyeska Investment Group
RA Capital Management
Sessa Capital IM

View all funds holding Grail